Takeda To Pay $22M To End Challenge To 401(k) Lineup

By Patrick Hoff (November 15, 2022, 1:19 PM EST) -- Takeda Pharmaceuticals agreed to pay $22 million to resolve a proposed class action accusing the company of loading its 401(k) plan with underperforming and high-cost investment options, according to a filing in Massachusetts federal court....

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.

  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!


Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!